Skip to content
Search

Latest Stories

Coronavirus outbreak threatens global drug supplies - European business group

The world's pharmacies may face a shortage of antibiotics and other drugs if supply problems from China's coronavirus outbreak cannot soon be resolved, the head of a European business group in China warned on Tuesday.

EU Chamber of Commerce President Joerg Wuttke added that Beijing was making supply chain problems worse with a mandatory quarantine of arrivals from abroad as it battles the virus, which has killed more than 1,800 Chinese mainly in the central province of Hubei.


Chinese media reported on Friday that the capital is requiring a 14-day quarantine for all arrivals, which Wuttke said would make it difficult to fly in technical experts to help if facilities are down.

Calling the measure unreasonable and against WHO guidelines, he told a roundtable in Beijing it would "cause more harm to business than many of the other things".

Wuttke also highlighted the difficulties faced by the auto industry due to disruption of deliveries of supplies in China, and surging inventories.

Companies are also running out of packaging material and face challenges with regulatory uncertainties, he said.

"The magnitude of the challenges is just really huge," he said.

He added that the disruption from the coronavirus epidemic had driven home the need to diversify away from China.

"People have now woken up to the fact that you must have a backup plan."

(Reuters)

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less